Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Samuel Kojo Kwofie, Dorothy Gyamfua Annan, Cynthia Ayefoumi Adinortey, Daniel Boison, Gabriel Brako Kwarko, Rachel Araba Abban & Michael Buenor Adinortey. (2022) Identification of novel potential inhibitors of varicella-zoster virus thymidine kinase from ethnopharmacologic relevant plants through an in-silico approach. Journal of Biomolecular Structure and Dynamics 40:23, pages 12932-12947.
Read now
Read now
Himal Lal, Toufik Zahaf & Thomas Heineman. (2013) Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su). Human Vaccines & Immunotherapeutics 9:7, pages 1425-1429.
Read now
Read now
Articles from other publishers (25)
Akshun Vyas, Bhaskar Sahu, Shelly Pathania, Nilay Kumar Nandi, Gaurav Chauhan, Vivek Asati & Bhupinder Kumar. (2022) An insight on medicinal attributes of pyrimidine scaffold: An updated review. Journal of Heterocyclic Chemistry 60:7, pages 1081-1121.
Crossref
Crossref
Erik De Clercq. (2022) FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?. Viruses 14:4, pages 770.
Crossref
Crossref
Samir Mohamed Awad, Shima Mahmoud Ali, Yara Essam Mansour & Samar Said Fatahala. (2021) Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents. Molecules 26:10, pages 2988.
Crossref
Crossref
Qian Wang, Nannan Zhu, Jiayuan Hu, Yan Wang, Jun Xu, Qiong Gu, Paul M. Lieberman & Yan Yuan. (2020) The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation. Journal of Biological Chemistry 295:21, pages 7431-7441.
Crossref
Crossref
Yuhki Ueda, Daisuke Uta, Soichiro Tanbo, Akiko Kawabata, Shoji Kanayama, Miho Osaki, Naoki Nozawa, Tatsumi Matsumoto & Tsugunobu Andoh. (2020) Inhibitory effect of amenamevir on acute herpetic pain and postherpetic neuralgia in mice infected with herpes simplex virus-1. Journal of Dermatological Science 98:1, pages 50-57.
Crossref
Crossref
Hanadi Sinokrot, Tasneem Smerat, Anas Najjar & Rafik Karaman. (2017) Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years. Molecules 22:10, pages 1736.
Crossref
Crossref
Jan Balzarini, Michael Menni, Kalyan Das, Lizette van Berckelaer, Alan Ford, Nuala M. Maguire, Sandra Liekens, Paul E. Boehmer, Eddy Arnold, Matthias Götte & Anita R. Maguire. (2017) Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses. Biochemical Pharmacology 136, pages 51-61.
Crossref
Crossref
Juliana Marotti. 2015. Lasers in Dentistry. Lasers in Dentistry
272
284
.
Ting Wu, Yan Wang & Yan Yuan. (2014) Antiviral activity of topoisomerase II catalytic inhibitors against Epstein–Barr virus. Antiviral Research 107, pages 95-101.
Crossref
Crossref
Kristine Macartney, Anita Heywood & Peter McIntyre. (2014) Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Joshua C. Pritchett, Lieve Naesens & Jose Montoya. 2014. Human Herpesviruses HHV-6A, HHV-6B & HHV-7. Human Herpesviruses HHV-6A, HHV-6B & HHV-7
311
331
.
Rachel Gordon, Stephen Tyring, Whitney Lapolla & Rana Mays. 2014. Acneiform Eruptions in Dermatology. Acneiform Eruptions in Dermatology
95
104
.
Erik De Clercq. (2013) A Cutting-Edge View on the Current State of Antiviral Drug Development. Medicinal Research Reviews 33:6, pages 1249-1277.
Crossref
Crossref
Kanchan M. Ganda. 2013. Dentist's Guide to Medical Conditions, Medications, and Complications. Dentist's Guide to Medical Conditions, Medications, and Complications
699
741
.
Erik De Clercq. (2013) Selective Anti-Herpesvirus Agents. Antiviral Chemistry and Chemotherapy 23:3, pages 93-101.
Crossref
Crossref
H. J. Field & R. A. Vere Hodge. (2013) Recent developments in anti-herpesvirus drugs. British Medical Bulletin 106:1, pages 213-249.
Crossref
Crossref
N. Coen, U. Singh, V. Vuyyuru, J. J. Van den Oord, J. Balzarini, S. Duraffour, R. Snoeck, Y. C. Cheng, C. K. Chu & G. Andrei. (2013) Activity and Mechanism of Action of HDVD, a Novel Pyrimidine Nucleoside Derivative with High Levels of Selectivity and Potency against Gammaherpesviruses. Journal of Virology 87:7, pages 3839-3851.
Crossref
Crossref
Rhina D. Castillo, Wendy De la Pena & Katherine A. B. Marzan. (2013) Diagnosis and Management of Infectious Complications of Childhood Rheumatic Diseases. Current Rheumatology Reports 15:4.
Crossref
Crossref
Erik De Clercq. (2013) Antivirals: Past, present and future. Biochemical Pharmacology 85:6, pages 727-744.
Crossref
Crossref
Carol L. Berkower, Nicole M. Johnson, Stephen B. Longdo, Shenika O. McGusty-Robinson, Samantha L. Semenkow & Barry J. Margulies. (2013)
Silicone-Acyclovir Controlled Release Devices Suppress Primary Herpes Simplex Virus-2 and Varicella Zoster Virus Infections
In Vitro
. Advances in Pharmacological Sciences 2013, pages 1-9.
Crossref
Crossref
Erik de Clercq. (2012) Milestones in the discovery of antiviral agents: nucleosides and nucleotides. Acta Pharmaceutica Sinica B 2:6, pages 535-548.
Crossref
Crossref
Erik De Clercq. (2012) Human viral diseases: what is next for antiviral drug discovery?. Current Opinion in Virology 2:5, pages 572-579.
Crossref
Crossref
A. Flatt & J. Breuer. (2012) Varicella vaccines. British Medical Bulletin 103:1, pages 115-127.
Crossref
Crossref
G. Andrei, D. Topalis, P. Fiten, C. McGuigan, J. Balzarini, G. Opdenakker & R. Snoeck. (2012)
In Vitro
-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs
. Journal of Virology 86:5, pages 2641-2652.
Crossref
Crossref
Beuy Joob & Viroj Wiwanitkit. (2012) Varicella pneumonia: a summary of Thai cases. Asian Pacific Journal of Tropical Biomedicine 2:3, pages S1867-S1868.
Crossref
Crossref